Identification of Exosomal circular RNA circSLC26A4 as a liquid biopsy marker for cervical cancer

The role of exosome circSLC26A4 in immune escape from cervical cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300072187

Enrollment

Unknown

Registered

2023-06-06

Start date

2023-05-30

Completion date

Unknown

Last updated

2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Cervical cancer patient group:No intervention measures

Healthy control group:N/A

Eligibility

Sex/Gender

Female

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Biopsy suggests cervical squamous cell carcinoma; Did not receive surgery, radiotherapy, chemotherapy, medication or other related treatment methods.

Exclusion criteria

Exclusion criteria: Other types of cervical malignancies; Previously suffering from or coexisting with malignant tumors in other areas; Patients who have received relevant treatment.

Design outcomes

Primary

Measure	Time frame
circSLC26A4;	—

Countries

China

Contacts

Public ContactHongjuan Li

Zhengzhou Central Hospital

lhj666777@163.com+86 152 3802 2969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026